drugset

drugset / Trial / NCT00904748

A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate

NCT00904748 ↗

Phase 1 Completed 47 enrolled Viatris Inc.

RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to perform a relative bioavailability study between two formulations of sildenafil citrate.

Timeline

Start: 2010-01
Primary completion: 2010-03
Completion: 2010-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	100 mg	—

Indications